"Het Jan Yperman Ziekenhuis is een modern, hoogtechnologisch ziekenhuis met 523 bedden, waar meer dan 1.250 medewerkers en 130 artsen elke dag het beste van zichzelf geven voor hun patiënten. De schaal van het ziekenhuis maakt het mogelijk gespecialiseerde zorg op topniveau aan te bieden, en tegelijk warm en overzichtelijk te blijven, op mensenmaat dus."

During the past decade, Jan Yperman Ziekenhuis conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 4 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jan Yperman Ziekenhuis" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Bayer" with 2 trials sponsored, "University Hospital, Ghent" with 2 trials sponsored, "AZ Delta" with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jan Yperman Ziekenhuis" #1 collaborator was "3M" with 1 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Agentschap voor Innovatie door Wetenschap en Technologie" with 1 trials as a collaborator, "Belgium Health Care Knowledge Centre" with 1 trials as a collaborator and "Belgium and Luxembourg Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Jan Yperman Ziekenhuis" are "Breast Cancer" (2 trials), "Breast Neoplasms" (2 trials), "Endometrial Cancer" (2 trials), "Multiple Myeloma" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Jan Yperman Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Jan Yperman Ziekenhuis" are "Drug" (14 trials), "Other" (4 trials), "Device" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Abemaciclib" (3 trials), "Rituximab" (2 trials), "Anastrozole" (1 trials) and "BAY2976217" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jan Yperman Ziekenhuis" are 20 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Jan Yperman Ziekenhuis". undefined are not yet recruiting, 2 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Jan Yperman Ziekenhuis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jan Yperman Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".

Jan Yperman Ziekenhuis has several departments that took part in Clinical trials: "Jan Yperman Ziekenhuis, Cardiology" - 2 trials